A5056073179- Bariatric Surgery and Outcomes
- Esophageal and GI Pathology
- Gastric Cancer Management and Outcomes
- Body Contouring and Surgery
- Minimally Invasive Surgical Techniques
- Diet and metabolism studies
- Gastroesophageal reflux and treatments
- Obesity and Health Practices
- Esophageal Cancer Research and Treatment
- Hernia repair and management
- Colorectal Cancer Surgical Treatments
- Gastrointestinal disorders and treatments
- Surgical Simulation and Training
- Pelvic and Acetabular Injuries
- Gastrointestinal Tumor Research and Treatment
- Gallbladder and Bile Duct Disorders
- Cardiac, Anesthesia and Surgical Outcomes
- Abdominal Surgery and Complications
- Diabetes Treatment and Management
- Anatomy and Medical Technology
- Appendicitis Diagnosis and Management
- COVID-19 and healthcare impacts
- Intestinal Malrotation and Obstruction Disorders
- Colorectal Cancer Screening and Detection
- Metastasis and carcinoma case studies
Centre Hospitalier Universitaire de Saint-Pierre
2015-2025
Centre Hospitalier Interrégional Edith Cavell
2016-2025
Université Libre de Bruxelles
1998-2022
Ziekenhuisnetwerk Antwerpen Stuivenberg
2022
AZ Sint-Blasius
2012-2021
RELX Group (United States)
2013-2019
RELX Group (United Kingdom)
2019
Philadelphia University
2013-2018
City College of San Francisco
2018
Desso (Belgium)
2013
In Brief Objective: To determine the mid- and long-term efficacy possible side effects of laparoscopic sleeve gastrectomy as treatment for morbid obesity. Summary Background Data: Laparoscopic is still controversial single final Some favorable short-term results have been published, however are lacking. Methods: period between November 2001 October 2002, 53 consecutive morbidly obese patients who, according to our personal algorithm, were qualified restrictive surgery selected gastrectomy....
Major updates to 1991 National Institutes of Health guidelines for bariatric surgery.
To determine the long-term efficacy and safety of laparoscopic adjustable gastric banding (LAGB) for morbid obesity.Clinical assessment in surgeon's office 2009 (≥12 years after LAGB).University obesity center Brussels, Belgium.A total 151 consecutive patients who had benefited from LAGB between January 1, 1994, December 31, 1997, were contacted evaluation.Laparoscopic banding.Mortality rate, number major minor complications, corrective operations, experienced weight loss, evolution...
MAJOR UPDATES TO 1991 NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR BARIATRIC SURGERY: Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity co-morbidities.MBS should be considered metabolic disease BMI 30-34.9 kg/m2.BMI thresholds adjusted in the Asian population such that >25 kg/m2 suggests clinical obesity, >27.5 offered MBS.Long-term results MBS consistently demonstrate safety...
This survey of international experts in obesity management was conducted to achieve consensus on standardized definitions and identify areas non-consensus metabolic bariatric surgery (MBS) assist an algorithm clinical practice guidelines for the obesity. A three-round Delphi with 136 statements by 43 comprising 26 surgeons, 4 endoscopists, 8 endocrinologists, 2 nutritionists, counsellors, internist, a pediatrician spanning six continents over 2-day meeting Hamburg, Germany. To reduce bias,...
Abstract Introduction The International Federation for Surgery Obesity and Metabolic Disorders (IFSO) Global Registry aims to provide descriptive data about the caseload penetrance of surgery metabolic disease obesity in member countries. presented this report represent key findings eighth IFSO Registry. Methods All existing Bariatric (MBS) registries known were invited contribute report. Aggregated was provided by each MBS registry team at Australia New Zealand (ANZBSR) securely stored on a...
Reoperations for complications of bariatric surgery are associated with high morbidity and mortality. It is not known whether endoscopic treatment may reduce reoperation rates.Twenty-one patients underwent persisting large anastomotic leaks before considering redo surgery. Eight had a gastric bypass, eight sleeve gastrectomy combined duodenal switch (SDS), four alone, one Scopinaro procedure (biliopancreatic diversion). Fistulas were gastrocutaneous in 15 patients, duodenocutaneous 2,...
Few data are available about obesity surgery in adolescent patients.To assess long-term outcomes after laparoscopic Roux-en-Y gastric bypass (LRYGB) patients <18 years.University Hospital, Europe.A retrospective study of prospectively collected years (childhood group; ChG) (n = 28) treated by LRYGB which 19 were for follow-up between 2.4 and 10.2 (mean 7.2 years). This group was matched with an adult control (AdG) randomly chosen similar characteristics who underwent during the same period....
Objective: To define “best possible” outcomes for bariatric surgery (BS)(Roux-en-Y gastric bypass [RYGB] and sleeve gastrectomy [SG]). Background: Reference values optimal surgical in well-defined low-risk patients have not been established so far. Consequently, outcome comparison across centers over time is impeded by heterogeneity case-mix. Methods: Out of 39,424 elective BS performed 19 high-volume academic from 3 continents between June 2012 May 2017, we identified 4120 RYGB 1457 SG...
The aim of the study was to report 10+ year outcome laparoscopic biliopancreatic diversion with duodenal switch (LDS), special focus on quality life.Reports long-term morbidity and life after LDS are rare.Records all patients who underwent years ago were analyzed. Patients contacted answer a questionnaire based Bariatric Analysis Reporting Outcome System. Blood work reported when performed within past year.Of 153 LDS, follow-up available for 113 (78.5%). Mean 130.2 ± 4.6 months. Percentage...